Joseph Pitts actually said...
While I do have some concerns about the process by which FDA is proposing this new regulatory approach, patient groups have questioned whether there are gaps in the current system that are jeopardizing patients' safety.
Context
Pitts expresses concerns about FDA's regulatory approach and patient safety issues.
09/08/2014